FFA
TGTX icon

Farther Finance Advisors’s TG Therapeutics TGTX Stock Holding History

Farther Finance Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$55.4K Buy
993
+312
+46% +$16.9K ﹤0.01% 3322
2026
Q2 		$37.5K Buy
681
+156
+30% +$6.38K ﹤0.01% 3484
2026
Q1 		$17.6K Buy
525
+143
+37% +$4.26K ﹤0.01% 3748
2025
Q4 		$11.4K Buy
382
+122
+47% +$3.98K ﹤0.01% 3828
2025
Q3 		$9.39K Buy
260
+30
+13% +$988 ﹤0.01% 3466
2025
Q2 		$8.27K Sell
230
-332
-59% -$12.4K ﹤0.01% 3170
2025
Q1 		$21.2K Buy
562
+359
+177% +$12.1K ﹤0.01% 2361
2024
Q4 		$6.11K Sell
203
-28
-12% -$804 ﹤0.01% 2579
2024
Q3 		$5.4K Buy
231
+18
+8% +$393 ﹤0.01% 2615
2024
Q2 		$3.86K Buy
213
+26
+14% +$415 ﹤0.01% 2510
2024
Q1 		$2.76K Buy
187
+27
+17% +$430 ﹤0.01% 2356
2023
Q4 		$2.73K Buy
160
+60
+60% +$697 ﹤0.01% 2293
2023
Q3 		$836 Buy
+100
New +$1.39K ﹤0.01% 2123
2023
Q1 		– Sell
-95
Closed -$1.12K – 2422
2022
Q4 		$1.12K Buy
+95
New +$690 ﹤0.01% 1623

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $348M AUM 25.11% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Farther Finance Advisors's TGTX Position: Q3 2026 in Review

Farther Finance Advisors increased its TG Therapeutics (TGTX) stake by 46% in Q3 2026, buying an estimated $16.9K and bringing the position to 993 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3322.

Farther Finance Advisors first reported a position in TGTX in Q4 2022 and has held it in 14 quarters since. 12 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Farther Finance Advisors held 993 shares of TG Therapeutics worth $55.4K as of Q3 2026.
  • Farther Finance Advisors bought 312 TG Therapeutics shares in Q3 2026, an estimated $16.9K.
  • TG Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3322 holding.
  • Farther Finance Advisors first reported a position in TG Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • 12 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.